Amphastar Pharmaceuticals Price to Free Cash Flow Ratio 2012-2026 | AMPH
Historical price to free cash flow ratio values for Amphastar Pharmaceuticals (AMPH) since 2012.
| Amphastar Pharmaceuticals Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-05-15 | 16.87 | 0.00 | |
| 2026-03-31 | 19.59 | $-0.49 | 0.00 |
| 2025-12-31 | 26.78 | 0 | 0.00 |
| 2025-09-30 | 26.65 | $2.33 | 11.41 |
| 2025-06-30 | 22.96 | $2.23 | 10.29 |
| 2025-03-31 | 28.99 | $2.92 | 9.92 |
| 2024-12-31 | 37.13 | $3.31 | 11.22 |
| 2024-09-30 | 48.53 | $3.32 | 14.63 |
| 2024-06-30 | 40.00 | $3.40 | 11.76 |
| 2024-03-31 | 43.91 | $3.02 | 14.52 |
| 2023-12-31 | 61.85 | $2.74 | 22.55 |
| 2023-09-30 | 45.99 | $2.61 | 17.65 |
| 2023-06-30 | 57.47 | $1.91 | 30.10 |
| 2023-03-31 | 37.50 | $0.99 | 38.00 |
| 2022-12-31 | 28.02 | $1.25 | 22.40 |
| 2022-09-30 | 28.10 | $1.75 | 16.05 |
| 2022-06-30 | 34.79 | $1.36 | 25.50 |
| 2022-03-31 | 35.90 | $1.97 | 18.24 |
| 2021-12-31 | 23.29 | $1.42 | 16.44 |
| 2021-09-30 | 19.01 | $0.90 | 21.17 |
| 2021-06-30 | 20.16 | $1.06 | 19.06 |
| 2021-03-31 | 18.32 | $0.92 | 19.84 |
| 2020-12-31 | 20.11 | $0.48 | 42.19 |
| 2020-09-30 | 18.75 | $0.26 | 71.35 |
| 2020-06-30 | 22.46 | $-0.21 | 0.00 |
| 2020-03-31 | 14.84 | $0.23 | 64.92 |
| 2019-12-31 | 19.29 | $0.00 | 0.00 |
| 2019-09-30 | 19.83 | $0.06 | 355.38 |
| 2019-06-30 | 21.11 | $0.54 | 38.76 |
| 2019-03-31 | 20.43 | $-0.46 | 0.00 |
| 2018-12-31 | 19.90 | $-0.18 | 0.00 |
| 2018-09-30 | 19.24 | $-0.18 | 0.00 |
| 2018-06-30 | 15.26 | $-0.45 | 0.00 |
| 2018-03-31 | 18.75 | $-0.32 | 0.00 |
| 2017-12-31 | 19.24 | $0.09 | 226.35 |
| 2017-09-30 | 17.87 | $0.28 | 64.56 |
| 2017-06-30 | 17.86 | $0.41 | 43.68 |
| 2017-03-31 | 14.50 | $0.46 | 31.30 |
| 2016-12-31 | 18.42 | $0.36 | 50.94 |
| 2016-09-30 | 18.97 | $0.16 | 119.99 |
| 2016-06-30 | 16.12 | $0.20 | 81.46 |
| 2016-03-31 | 12.00 | $0.16 | 75.61 |
| 2015-12-31 | 14.23 | $-0.12 | 0.00 |
| 2015-09-30 | 11.69 | $-0.02 | 0.00 |
| 2015-06-30 | 17.58 | $0.24 | 73.10 |
| 2015-03-31 | 14.96 | $-0.05 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.924B | $0.720B |
| Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |